Iovance Biotherapeutics (2LB.F) Q4 2023 Earnings

28FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.42
-0.41
-0.4
-0.4

Details

Expected EPS
-0.39744654884999997
Actual EPS
-0.4151745
Surprise EPS
-0.02
Surprise Percent
+4.46%

Description

Iovance Biotherapeutics (2LB.F) has reported earnings of -0.4151745 per share for Q4 2023.

0 Comments

Share your thoughts